Inactive Instrument
Isodiol International Inc Stock Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.75M 2.41M 2.22M 2.06M 262M 3.96M 26.56M 10.34M 129M 10.33M 10.1M 447M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.42M 5.63M 5.18M 4.81M 613M 9.26M 62.03M 24.14M 301M 24.12M 23.59M 1.04B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.58% | +881.08% | - | - | 128 | ||
| +0.86% | +1.55% | -11.67% | -4.90% | 12.94B | ||
| +1.50% | +0.68% | -33.62% | -55.63% | 4.79B | ||
| +0.96% | +3.80% | -7.08% | -2.70% | 4.49B | ||
| +0.30% | +5.58% | +23.58% | -1.26% | 3.92B | ||
| +1.15% | +1.67% | +5.33% | -37.13% | 3.89B | ||
| +3.07% | +5.48% | -9.42% | +6.42% | 3.17B | ||
| +3.78% | -11.63% | -10.45% | -14.58% | 3.16B | ||
| +1.63% | +2.24% | -6.44% | -22.75% | 2.41B | ||
| +2.80% | +7.03% | -9.40% | +39.83% | 1.77B | ||
| Average | +1.25% | +6.12% | -6.57% | -10.30% | 4.5B | |
| Weighted average by Cap. | +1.45% | +5.31% | -8.03% | -12.37% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.46M 11.79M 10.86M 10.08M 1.28B 19.4M 130M 50.58M 630M 50.54M 49.44M 2.18B | 22.25M 15.65M 13.7M 12.62M 11.72M 1.49B 22.55M 151M 58.8M 733M 58.76M 57.47M 2.54B |
| Net income | -36.02M -25.33M -22.19M -20.44M -18.97M -2.42B -36.51M -245M -95.2M -1.19B -95.14M -93.05M -4.11B | -126M -88.55M -77.56M -71.43M -66.31M -8.45B -128M -855M -333M -4.15B -333M -325M -14.38B |
| Net Debt | -15.55M -10.94M -9.58M -8.82M -8.19M -1.04B -15.76M -106M -41.1M -512M -41.07M -40.17M -1.78B | 5.22M 3.67M 3.22M 2.96M 2.75M 350M 5.29M 35.46M 13.8M 172M 13.79M 13.49M 596M |
Employees
-
Sector
Pharmaceuticals
















